Jessica Lam

Recent representative matters include acting as counsel to:

• Various multinational pharmaceutical and medical device manufacturers in class actions involving a wide variety of medicines and devices, including pelvic and hernia mesh implants, CPAP devices, hospital equipment, and an antacid medication

• Leading multinational pharmaceutical and medical device manufacturers and distributors in the defence of individual product liability actions involving surgical devices and hospital equipment, ankle replacement parts, and breast implants

• A leading cannabis company in a class action alleging negligence and failure to warn

• A North American vehicle manufacturer in class actions alleging negligent design, testing and manufacture, and breaches of consumer protection laws

• A gaming facility and public-sector entity in successfully opposing the plaintiffs' motion for certification in a privacy class action arising out of a cyber-attack

• A multinational hotel franchise in a class action involving allegations of deceptive trade practices

• A large media organization in a constitutional challenge relating to freedom of information legislation

• Co-author: Divisional Court Affirms That Exposure to Increased Risk of Harm Is Not Actionable
  Blakes Bulletin on Litigation & Dispute Resolution, July 5, 2023.
• Co-author: P.E.I. Adopts Ontario Class Action Model in New Legislation
  Blakes Bulletin on Class Actions, March 28, 2022.
• Co-author: Bourque v. Insight: First Class Proceeding to be Dismissed for Delay Under the New s.29.1 of the Amended Class Proceedings Act
  OBA, February 15, 2022.

• Speaker: What Goes First? Sequencing Issues in Class Actions
  Canadian Bar Association, March 3, 2021.
• Speaker: Privacy Breaches on a Class Action Scale
  Ontario Bar Association, October 16, 2020.

Admitted to the Ontario Bar – 2014
JD, University of Toronto – 2013
BJourn (Hon.), Ryerson University – 2009